Literature DB >> 22884262

Characterization of Brucella abortus infection of bovine monocyte-derived dendritic cells.

M C Heller1, J L Watson, M T Blanchard, K A Jackson, J L Stott, R M Tsolis.   

Abstract

Brucella abortus is a Gram negative facultative intracellular pathogen of cattle, and an important zoonosis in humans worldwide. Previous studies have shown that dendritic cells (DC) from humans and mice are highly permissive for Brucella survival and proliferation. Impairment of DC activation and maturation by Brucella infection has also been reported in these two species. The aim of this study was to characterize infection of bovine DC with B. abortus. Monocyte-derived DC (mdDC) were cultured from bovine peripheral blood mononuclear cells (PBMC) using the recombinant bovine cytokines IL-4 and GM-CSF. The resulting mdDC were DEC205(+), MHC class II(hi). Approximately 70% of the cultured cells were DEC205(+), MHC II(+). MdDC were infected with B. abortus strain 2308 at an MOI of 1 and 100. Parallel infection experiments were performed in monocyte derived macrophages (mdM) isolated from the same subjects. Bacteria were successfully killed by mdDC by 24 hours post infection (PI) with high and low dose of B. abortus, bacteria persisted in mdM infected with a high dose. Expression of IL-1b, IL-6, IL-10, IL-12p40, IFNγ, iNOS and TNFα in B. abortus infected and LPS stimulated mdDC at 6 and 24 hours PI were evaluated using RT-qPCR. At 6 hours PI all transcripts were increased over control cells and significantly less IL-10, IL-12p40, and IFNγ were expressed in mdDC infected with B. abortus compared to LPS stimulation. Evaluation of mdDC cultures by flow cytometry was performed. Flow cytometric analysis of infected and LPS stimulated mdDC 24 hours PI showed expression of CD80 and CD86 was impaired in two of the three animals analyzed. MHC class II expression was equivocal between the groups. From these results we conclude that cultured bovine mdDC are not permissive for intracellular proliferation of B. abortus, and infected mdDC exhibit some signs of maturational and activational impairment.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22884262     DOI: 10.1016/j.vetimm.2012.07.006

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  6 in total

1.  Phenotypic, ultra-structural, and functional characterization of bovine peripheral blood dendritic cell subsets.

Authors:  Janet J Sei; Amanda S Ochoa; Elizabeth Bishop; John W Barlow; William T Golde
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

Review 2.  Dendritic cells and Brucella spp. interaction: the sentinel host and the stealthy pathogen.

Authors:  Eric Daniel Avila-Calderón; Leopoldo Flores-Romo; Witonsky Sharon; Luis Donis-Maturano; Miguel Angel Becerril-García; Ma Guadalupe Aguilera Arreola; Beatriz Arellano Reynoso; Francisco Suarez Güemes; Araceli Contreras-Rodríguez
Journal:  Folia Microbiol (Praha)       Date:  2019-02-19       Impact factor: 2.099

3.  Risk factors for new bovine brucellosis infections in Colombian herds.

Authors:  Liliana Cárdenas; Mario Peña; Oscar Melo; Jordi Casal
Journal:  BMC Vet Res       Date:  2019-03-07       Impact factor: 2.741

4.  Identification of Dendritic Cell Maturation, TLR, and TREM1 Signaling Pathways in the Brucella canis Infected Canine Macrophage Cells, DH82, Through Transcriptomic Analysis.

Authors:  Woo Bin Park; Suji Kim; Soojin Shim; Han Sang Yoo
Journal:  Front Vet Sci       Date:  2021-03-19

Review 5.  Immunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases.

Authors:  Joaquin Miguel Pellegrini; Jean-Pierre Gorvel; Sylvie Mémet
Journal:  Microorganisms       Date:  2022-06-21

6.  Brucella discriminates between mouse dendritic cell subsets upon in vitro infection.

Authors:  Alexia Papadopoulos; Aurélie Gagnaire; Clara Degos; Chantal de Chastellier; Jean-Pierre Gorvel
Journal:  Virulence       Date:  2015-11-25       Impact factor: 5.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.